Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion

• Published in: Medical oncology (Northwood, London, England) Vol. 29; no. 5; pp. 3306 - 3313
• Main Authors: Ma, Jian-Jun, Kong, Ling-Min, Liao, Cheng-Gong, Jiang, Xue, Wang, Yong, Bao, Ting-Yi
• Format: Journal Article
• Language: English
• Published: Boston Springer US 01.12.2012; Springer Nature B.V
• Subjects: Blotting, Western; Carcinoma, Renal Cell - metabolism; Carcinoma, Renal Cell - mortality; Carcinoma, Renal Cell - pathology; Female; Gene Knockdown Techniques; Hematology; Humans; Immunohistochemistry; Internal Medicine; Kaplan-Meier Estimate; Kidney Neoplasms - metabolism; Kidney Neoplasms - mortality; Kidney Neoplasms - pathology; Male; Matrix Metalloproteinase 9 - metabolism; Medicine; Medicine & Public Health; Middle Aged; Neoplasm Invasiveness - pathology; Neoplasm Staging; Oncology; Original Paper; Pathology; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Proteins - metabolism; NDRG2; CCRCC; MMP-9; Survival; Prognostic indicator; Invasion
• ISSN: 1357-0560; 1559-131X
• DOI: 10.1007/s12032-012-0265-1

Members of the NDRG (N-Myc downstream-regulated) gene family have been shown to play a variety of roles in human malignancies. Recently, it was shown decreased expression in clear cell renal cell carcinoma (CCRCC) and inhibited cell proliferation, but the role of the NDRG2 in CCRCC invasion has not been described. We examined the expression of NDRG2 protein in CCRCC samples and the association between NDRG2 expression and CCRCC patients survival. Real-time RT-PCR and immunohistochemical analysis were used to measure NDRG2 expression in 60 paired CCRCC and adjacent normal tissues. Changes in cell invasion were detected by up- or down-regulating NDRG2 by adenovirus or siRNA. We found that NDRG2 expression is significantly down-regulated in CCRCC at mRNA and protein levels in a manner negatively associated with aggressive tumor behaviors, such as TNM stage ( P  = 0.003), Fuhrman’s grade ( P  = 0.024), tumor invasion ( P  = 0.001) and tumor recurrence ( P  = 0.004), as well as shorter patient survival rates ( P  = 0.0041). Furthermore, NDRG2 could suppress CCRCC cell invasion through regulating MMP-9 expression and activity. So, these results suggest that NDRG2 can inhibit extracellular matrix-based tumor cell invasion and thereby play important roles in suppressing tumor metastasis in CCRCC. NDRG2 expression may also be a significant prognostic indicator for CCRCC.